SCIE (SpectraScience) Other Long-Term Liabilities : $0.03 Mil (As of Sep. 2017)

View and export this data going back to . Start your Free Trial

What is SpectraScience Other Long-Term Liabilities?

SpectraScience's other long-term liabilities for the quarter that ended in Sep. 2017 was $0.03 Mil.

SpectraScience's quarterly other long-term liabilities increased from Mar. 2017 ($0.03 Mil) to Jun. 2017 ($0.03 Mil) but then stayed the same from Jun. 2017 ($0.03 Mil) to Sep. 2017 ($0.03 Mil).

SpectraScience's annual other long-term liabilities declined from Dec. 2014 ($0.03 Mil) to Dec. 2015 ($0.03 Mil) and declined from Dec. 2015 ($0.03 Mil) to Dec. 2016 ($0.03 Mil).

SpectraScience Other Long-Term Liabilities Historical Data

The historical data trend for SpectraScience's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SpectraScience Other Long-Term Liabilities Chart

SpectraScience Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Other Long-Term Liabilities

Get a 7-Day Free Trial

SpectraScience Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

SpectraScience Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

SpectraScience Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of SpectraScience's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

SpectraScience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraScience Inc (GREY:SCIE) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

11568-11 Sorrento Valley Road, San Diego, CA, USA, 92121

Website

http://www.spectrascience.com

SpectraScience Inc is a US based company focused on developing the WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The firm has developed a technology platform to determine if the tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT operates by using cool, safe UV laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin treatment during the same procedure. The group sells its product in the United States and Europe, of which majority of the sales revenue is derived from the United States.

Executives

Lowell Giffhorn	officer: CFO	10875 KEMAH LANE, SAN DIEGO CA 92131
John Pappajohn	director	1660 WALT WHITMAN ROAD, SUITE 105, MELVILLE NY 11747
Euclidsr Partners, L.p.	10 percent owner	45 ROCKEFELLER PLAZA, SUITE 3240, NEW YORK NY 10111
Euclidsr Associates, L.p.	10 percent owner	45 ROCKEFELLER PLAZA, SUITE 3240, NEW YORK NY 10111
Tommy G Thompson	director	7711 CARONDELET, ST. LOUIS MO 63105

SpectraScience Headlines

No Headlines